Are Peptides coming off of the FDA Category 2 list? A legal breakdown. BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The Blacklisting of Peptides The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA Peptide Regulation and HHS Policy Holt Law